Inhalon
Ellen Farmer's work experience includes:
- Scientist at Inhalon Biopharma starting in December 2022.
- Scientist and Associate Scientist at Catalent Pharma Solutions from October 2019 to December 2022.
- Graduate Student Researcher and Graduate Teaching Assistant at North Carolina State University from August 2017 to May 2019.
- Toxicology Specialist at Lab Test Diagnostics from May 2017 to August 2017.
- Chemistry Analyst I at DYNALABS LLC from November 2016 to April 2017.
- Lab Technician at Mycorrhizal Applications, LLC from August 2016 to October 2016.
- Undergraduate Student Researcher, Laboratory Teaching Assistant, Chemical Stock Room Worker, and Undergraduate Student Researcher at Truman State University from September 2013 to May 2016.
- Summer Research Student at Lehigh University from May 2014 to July 2014.
- Games Hostess at Six Flags from March 2011 to October 2011.
Ellen Farmer pursued their education in a chronological manner. Ellen earned a Bachelor of Science (B.S.) degree in Chemistry from Truman State University from 2012 to 2016. Following this, they attended North Carolina State University from 2017 to 2019, where they obtained a Master of Science (M.S.) degree in Materials Sciences and Engineering.
Inhalon
Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections (ARI), such as syncytial virus (RSV), influenza, metapneumovirus (MPV), parainfluenza virus (PIV), adenovirus, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Today there are no approved treatments for a wide range of ARIs that can lead to hospitalization, long-term health complications, and sometimes death.